Can You Still Conceive Naturally with AMH 1.1 at Age 35? A Detailed Guide to IVF-PGT in the U.S. and Mexico

2026-04-22 20:39:51，浏览量： 17次

As delayed marriage and childbearing become increasingly common, many professional women around the age of 35 are facing a sudden decline in fertility. Careers may be on the rise, but menstrual cycles begin to show irregularities, and months of trying to conceive bring no results, creating both anxiety and uncertainty. As a key indicator of ovarian reserve, a low AMH level often becomes a turning point in the fertility journey.

 

AMH (Anti-Müllerian Hormone) reflects the number of remaining follicles in the ovaries. For women aged 35, a normal level is typically above 1.5, and a value of 1.1 is considered below average, indicating a noticeable decline in available egg reserve. This does not mean fertility is completely lost, but both the probability of natural conception and egg quality may be affected. Lulu (pseudonym) is one such case. As a senior creative director at an advertising agency, she postponed childbearing for career development after five years of marriage. Recently, her sister’s AMH was found to be only 0.78 during fertility testing, which prompted her to undergo a comprehensive fertility assessment. Her results showed an AMH of 1.1 and an antral follicle count below the average for her age.

 

Why choose IVF-PGT in the U.S. and Mexico

 

After reviewing the results, Lulu and her husband carefully considered their options and decided to preserve fertility through IVF in the U.S. and Mexico. Doctors recommended an IVF-PGT approach, involving ovarian stimulation to retrieve eggs, fertilization with sperm to form blastocysts, followed by comprehensive chromosomal screening. Healthy embryos are then selected and frozen. This method allows abnormal embryos to be excluded in advance, significantly improving implantation success rates and healthy live birth outcomes.

 

Unlike egg freezing alone, embryo freezing occurs after fertilization, allowing direct use after thawing for transfer and reducing certain uncertainties. The advantage of the U.S. and Mexico IVF system lies in its mature laboratory techniques. The entire process—from online evaluation to short stays for egg retrieval and personalized transfer planning—is designed around individual schedules, minimizing the stress of repeated long-distance travel.

 

Fertility strategies for women with low AMH

 

For 35-year-old women with low AMH, relying solely on natural conception or conventional IVF often yields limited success. The screening capabilities of IVF-PGT in the U.S. and Mexico allow for precise selection of high-quality embryos, making each transfer more predictable. Lulu ultimately chose egg freezing, balancing her current career priorities while securing future possibilities for a healthy pregnancy. Many women in similar situations, after completing standardized cycles, not only achieve successful pregnancies but also preserve additional high-quality embryos for future family planning.

When AMH levels signal a warning as early as age 35, many families begin to see a clearer path forward with professional international support. IVF USA, founded by Dr. Nathan Zhang, has been engaged in overseas assisted reproduction consulting services for more than a decade, providing U.S. egg freezing, U.S. IVF, and third-party reproductive services to those in need. With nearly 20 years of experience in the international assisted reproduction field, IVF USA has, in response to increasingly diverse and personalized reproductive needs, strategically expanded into the Mexico market early on, becoming the China representative of Power Fertility Center (POWER IVF) in Mexico. Currently, Dr. Nathan Zhang’s services have expanded beyond the United States to include IVF and egg freezing in Mexico, Japan, Thailand, as well as regions such as Taiwan and Hong Kong, helping more individuals regain control over their fertility at different stages of life and move step by step toward the goal of a healthy and complete family.